COMPASS Pathways plc

WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
CUSIP
20451W101
SEDOL
BMC3HS7
CIK
0001816590
compasspathways.com
LEI:
©
FIGI: BBG00X0VY2N1
CMPS
COMPASS Pathways plc
GICS: - · Sektor: Healthcare · Sub-Sektor: Medical Care Facilities
NAME
COMPASS Pathways plc
ISIN
US20451W1018
TICKER
CMPS
MIC
XNAS
REUTERS
CMPS.OQ
BLOOMBERG
CMPS US
BUILD THEMEFOLIO IDEEN TEILEN DISKUTIEREN
HEBEL INVESTIEREN
GIF DE 728x90
Financial Intelligence
360° iHub Crowd ATH Tracker Index Tracker ETF TF Spicy X-Billboard
FÜR INVESTOREN
FÜR TRADER
Börsenhandel Warrants
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von BusinessWire bereitgestellt.
Do., 31.10.2024       COMPASS Pathways
US20451W1018

Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, today reported its financial results for the third quarter 2024 and an update on recent business progress. “Ensuring the success of our lead COMP360 program is our absolute priority. We remain co...
weiterlesen
COMPASS Pathways
Research & Analysen Termsheet Terminal
Permalink
Do., 24.10.2024       COMPASS Pathways
US20451W1018

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the third quarter 2024 ending September 30, 2024, and provide an update on recent business developments, on October 31, 2024. The management...
weiterlesen
COMPASS Pathways
Research & Analysen Termsheet Terminal
Permalink
Mo., 23.09.2024       COMPASS Pathways
US20451W1018

Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, announced today that executives from the management team will be participating in a fireside chat at the Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit on September 26, 2024 at ...
weiterlesen
COMPASS Pathways
Research & Analysen Termsheet Terminal
Permalink
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Informationen zu Product Placements